Your browser doesn't support javascript.
loading
Diagnosis of metachromatic leukodystrophy in a patient with regression and Phelan-McDermid syndrome.
Ahn, Hyunji; Seo, Go Hun; Keum, Changwon; Heo, Sun Hee; Kim, Taeho; Choi, Jeongmin; Yum, Mi-Sun; Lee, Beom Hee.
Affiliation
  • Ahn H; Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Seo GH; 3 Billion, Inc., Seoul, Republic of Korea.
  • Keum C; 3 Billion, Inc., Seoul, Republic of Korea.
  • Heo SH; ASAN Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Kim T; ASAN Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Choi J; ASAN Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Yum MS; Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: yumyum99@daum.net.
  • Lee BH; Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea; ASAN Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: bhlee@amc.seoul.kr.
Brain Dev ; 42(5): 414-417, 2020 May.
Article in En | MEDLINE | ID: mdl-32113700
ABSTRACT
Phelan-McDermid syndrome (PMS) is a 22q13.3 deletion syndrome. Most PMS patients show global developmental delay and some of them suffer from developmental regression. The deleted region contains ARSA, which is responsible for metachromatic leukodystrophy (MLD). Here we report an extremely rare case of PMS characterized by unusual, rapidly progressive developmental regression due to additional pathogenic mutation in ARSA. Considering the 1 in 100 chance of an MLD carrier, co-occurrence of PMS and MLD in a patient is possible if either parent carries a heterozygous ARSA mutation. Therefore, MLD should be ruled out in PMS patients with severe neurological phenotype.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosome Disorders / Leukodystrophy, Metachromatic Type of study: Diagnostic_studies Limits: Child, preschool / Humans / Male Language: En Journal: Brain Dev Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosome Disorders / Leukodystrophy, Metachromatic Type of study: Diagnostic_studies Limits: Child, preschool / Humans / Male Language: En Journal: Brain Dev Year: 2020 Document type: Article